Condition: Peritoneal Carcinomatosis · Pseudomyxoma Peritonei · Peritoneal Mesothelioma · Sponsor: Universitaire Ziekenhuizen KU Leuven
The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.
This description comes directly from the study's public registry record.
Isabelle B Terrasson · +32 16 340837 · isabelle.terrasson@uzleuven.be
Always discuss trial participation with your own doctor first.
| University Clinics Gasthuisberg | Leuven, Flemish Brabant, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01617382